UNSPSC 51204208: Clostridium botulinum vaccine

The first vaccine used to protect against botulinum neurotoxin was a chemically detoxified extract from Clostridium botulinum. A Pentavalent botulinum toxoid (PBT) vaccine in service today is administered under an Investigational New Drug (IND) application held by the CDC.

UNSPSC 51204208 Clostridium botulinum vaccine is a Commodity code under which state and local health departments procure immunization products, though recent activity shows procurement patterns that diverge from the code's nominal scope. The Mississippi State Department of Health posted a sole source notice in July 2026 for Yellow Fever Vaccine from Sanofi Pasteur, Inc., indicating that state health agencies use vaccine-related codes to acquire immunization supplies across product lines rather than strictly adhering to botulinum-specific classification. State health departments emerge as the primary issuing bodies under this code, purchasing vaccines as part of public health and disease prevention operations.

The geographic spread of recent activity is limited to Mississippi based on the available record. The Mississippi State Department of Health's July 2026 sole source notice for Yellow Fever Vaccine (due August 3, 2026) represents the sole recent opportunity visible under this code; the notice was not a standard competitive RFP or IFB but rather a proposed sole source purchase subject to objection and potential competitive re-solicitation if alternative sources could be demonstrated. The absence of quantity, contract term, estimated value, or pricing detail in the notice limits visibility into transaction scale. The code shows minimal recent procurement velocity in state and local markets.